Express Scripts’ new formulary ejects some drugs once thought 'untouchable': analysts

10th August 2018 Uncategorised 0

Many of the specialty drugs excluded from Express Scripts’ 2019 formulary, such as Gilead’s Atripla for HIV, seemed safe—but not anymore, the pharmacy benefits manager said. And that change of strategy could hit the top lines of not just Gilead but also AbbVie, Sanofi and more, analysts fear.

More: Express Scripts’ new formulary ejects some drugs once thought 'untouchable': analysts
Source: fierce